All Updates

All Updates

icon
Filter
Funding
PatSnap raises USD 300 million in Series E financing
AI Drug Discovery
Mar 16, 2021
This week:
Partnerships
Microsoft and BlackRock partner to launch USD 30 billion AI data center investment fund
Machine Learning Infrastructure
Yesterday
Funding
Limitless Labs raises USD 3 million in pre-seed funding to develop prediction market
Web3 Ecosystem
Yesterday
Product updates
Google Cloud launches Blockchain RPC service for Web3 developers
Web3 Ecosystem
Yesterday
Product updates
Kore.ai launches GALE platform for enterprise GenAI adoption
Machine Learning Infrastructure
Yesterday
Product updates
Kore.ai launches GALE platform for enterprise GenAI adoption
Generative AI Infrastructure
Yesterday
Partnerships
Climeworks partners with Terraset to enable philanthropic support for carbon removal
Carbon Capture, Utilization & Storage (CCUS)
Sep 17, 2024
Funding
8 Rivers secures investment from JX Nippon to commercialize DAC technology
Carbon Capture, Utilization & Storage (CCUS)
Sep 17, 2024
Product updates
ProAmpac launches enhanced online pouch configurator MAKR by DASL for custom flexible packaging prototypes
Smart Packaging Tech
Sep 17, 2024
Funding
M&A
Majority stake in Bollegraaf Group acquired by Summa Equity for EUR 800 million
Waste Recovery & Management Tech
Sep 17, 2024
Partnerships
NASA awards Intuitive Machines contract for near-space network services
Space Travel and Exploration Tech
Sep 17, 2024
AI Drug Discovery

AI Drug Discovery

Mar 16, 2021

PatSnap raises USD 300 million in Series E financing

Funding

  • PatSnap, an AI patent intelligence platform based between Singapore and the UK, has raised USD 300 million in a Series E funding round led by SoftBank Vision Fund 2 and Tencent Investment, with participation from CITIC Industrial Fund, Sequoia China, and Vertex Ventures. This brings the company’s total funds raised to USD 351.6 million, with its valuation reportedly crossing USD 1 billion. 

  • The proceeds will be used to further develop the company’s intelligence platform, accelerate software product development, and expand the global sales team. 

  • Founded in 2007, PatSnap operates a software platform that uses AI to combine millions of data points from patents, licensing, litigation, and other sources to provide intelligence that helps companies streamline R&D. The company’s products can be used across various sectors and its life science-focused product, PatSnap Bio, allows pharmaceutical companies to search for protein, DNA, and RNA sequences within patent and non-patent sources to improve their R&D process.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.